IDXGInterpace Biosciences, Inc.

About Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences, Inc. (IDXG) is a Diagnostics & Research company headquartered in Parsippany, NJ, United States whose shares trade over-the-counter on the OTCQX tier.

Interpace Biosciences is an emerging leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications.

Products and services

Interpace Biosciences provides clinical molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer.

IDXG key facts

Ticker symbol

IDXG

Market tier

OTCQX

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Parsippany, NJ, United States

Country of incorporation

US

Year of incorporation

1998

Employees

121

Estimated market cap

$5.65M (as of Apr 10, 2025)

Shares outstanding

4,414,904

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Interpace Biosciences, Inc. leadership

• Thomas W. Burnell — CEO
• Christopher McCarthy — CFO, Principal Fin. Officer, VP, Fin.

Explore more: Diagnostics & Research stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with I